Dietary Supplementation with Silymarin Inhibits 3,2′-Dimethyl-4-Aminobiphenyl–Induced Prostate Carcinogenesis in Male F344 Rats
Authors:
- 1 July 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (13) , 4962-4967
Abstract
Purpose: Silymarin has been shown to be a potent anticarcinogenic agent. Here, we investigated the modifying effects of dietary feeding with a naturally occurring polyphenolic antioxidant flavonoid silymarin on 3,2′-dimethyl-4-aminobiphenyl (DMAB)–induced prostatic carcinogenesis in male F344 rats. Experimental Design: Male F344 rats were given s.c. injections of DMAB (25 mg/kg body weight) every other week for 20 weeks. They also received the experimental diet containing 100 or 500 ppm silymarin for 40 weeks, starting 1 week after the last dosing of DMAB. All of the rats were sacrificed 60 weeks after the start of the experiment. Histopathology and immunohistochemistry for proliferative cell nuclear antigen, cyclin D1, and apoptotic indices were done in the prostatic lesions, including invasive adenocarcinomas, intraepithelial neoplasms, and nonlesional glands. Results: Dietary feeding with 500 ppm silymarin significantly inhibited the incidence of prostatic adenocarcinoma when compared with the DMAB-alone group (17.6% versus 50.0%, P < 0.05). The proliferative cell nuclear antigen– and cyclin D1–positive indices in adenocarcinomas, prostatic intraepithelial neoplasm, and nonlesional glands in rats treated with DMAB and silymarin were slightly lower than that of the DMAB-alone group. Also, dietary administration of silymarin increased apoptotic index in prostatic adenocarcinoma by measuring immunohistochemically positive nuclei for ssDNA. Conclusions: Our results indicate that silymarin exerts chemopreventive ability against chemically induced prostatic carcinogenesis through apoptosis induction and modification of cell proliferation.Keywords
This publication has 35 references indexed in Scilit:
- Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cellsThe Prostate, 2002
- Chemopreventive Effects of a Flavonoid Antioxidant Silymarin on N‐Butyl‐N‐(4‐ hydroxybutyl)nitrosamine‐induced Urinary Bladder Carcinogenesis in Male ICR MiceJapanese Journal of Cancer Research, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Beef Tallow, but Not Perilla or Corn Oil, Promotion of Rat Prostate and Intestinal Carcinogenesis by 3,2‐Dimethyl‐4‐aminobiphenylJapanese Journal of Cancer Research, 2001
- Cancer Incidence and Incidence Rates in Japan in 1995: Estimates Based on Data from Nine Population-based Cancer RegistriesJapanese Journal of Clinical Oncology, 2000
- Detection of Apoptotic Cells in Human Colorectal Cancer by Two Different in situ Methods: Antibody against Single‐stranded DNA and Terminal Deoxynucleotidyl Transferase‐mediated dUTP‐biotin Nick End‐labeling (TUNEL) MethodsJapanese Journal of Cancer Research, 1999
- Skin Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin Are Mediated via Impairment of Receptor Tyrosine Kinase Signaling and Perturbation in Cell Cycle ProgressionBiochemical and Biophysical Research Communications, 1998
- Cell Proliferation and CarcinogenesisDrug Metabolism Reviews, 1998
- Novel Cancer Chemopreventive Effects of a Flavonoid Antioxidant Silymarin: Inhibition of mRNA Expression of an Endogenous Tumor Promoter TNFαBiochemical and Biophysical Research Communications, 1997
- Cyclins and oncogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1993